Status:
NOT_YET_RECRUITING
Evaluation of the Efficacy of Electroacupuncture in the Treatment of Chronic Atrophic Gastritis
Lead Sponsor:
Yi Liang
Collaborating Sponsors:
Zhejiang Provincial Department of Science and Technology
Conditions:
Chronic Atrophic Gastritis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Brief Summary Template for the Study: This clinical trial aims to evaluate whether electroacupuncture can treat chronic atrophic gastritis (CAG) in adult subjects aged 18 to 75 years (including both ...
Eligibility Criteria
Inclusion
- Meets the diagnostic criteria for chronic atrophic gastritis (CAG) (at the time of enrolment, participants must provide reports from endoscopic and pathological examinations conducted within the past year prior to the study start date, both of which indicate chronic atrophic gastritis)
- Age between 18 and 75 years old, no gender restrictions;
- Has not received acupuncture treatment within the past month;
- Not participated in any other ongoing studies within the past 2 months.
- Understand and agree to participate in this study and sign the informed consent form.
Exclusion
- Autoimmune gastritis (type A chronic atrophic gastritis);
- Participants with a positive C-13 urea breath test at baseline (Helicobacter pylori infection);
- Patients diagnosed with high-grade intraepithelial neoplasia based on upper gastrointestinal endoscopy and gastric mucosal biopsy pathology;
- Patients with confirmed or unresolved malignant tumours, particularly oesophageal cancer and gastric cancer; patients with other upper gastrointestinal lesions such as peptic ulcers or Barrett's oesophagus;
- Patients with severe lesions in major organs (heart, liver, kidney, lung, etc.) or other autoimmune diseases (rheumatic diseases, Crohn's disease, autoimmune pancreatitis, etc.); Persons with cardiac pacemakers;
- Pregnant and lactating women;
- Patients with infectious diseases such as tuberculosis, hepatitis, or HIV/AIDS;
- Individuals with a history of alcohol abuse, drug use, or illicit drug use;
- Individuals who have used other prokinetic agents, mucosal protectants, acid-suppressing medications, or related traditional Chinese medicines within the past two weeks;
- Individuals currently participating in or who have participated in other clinical trials within the past two months; individuals unable to tolerate acupuncture or with contraindications for acupuncture treatment; and individuals deemed unsuitable for participation in this clinical trial by the research team.
Key Trial Info
Start Date :
December 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07152860
Start Date
December 30 2025
End Date
December 30 2026
Last Update
December 19 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine)
Hangzhou, Zhejiang, China, 310007
2
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China, 310053
3
The Third Affiliated Hospital of Zhejiang Chinese Medicinal University
Hangzhou, Zhejiang, China, 310053